The pharmaceuticals sector has been under prolonged attack from competition, government regulstors and customore lawsuits, presenting a unique IR challenge
The Amex-quoted pharmaceuticals index reached its all-time high at the end of 2000 when, in the middle of a market meltdown and with recession on the cards, investors fled high-flying tech and biotech stocks for safer ones in more defensive sectors. The pharma sector had seen 350 percent returns over the previous six years and people would continue to buy prescriptions, even during a recession.However, between those heady days at the beginning of the millennium and the end of 2004, the pharma
You need to register to access 3 free deep dive articles per month. To continue reading please register or login below..
- Unlimited deep dives
- Data-driven research around key topics
- Buy-side insights
- Benchmarking reports
From
$1495
